Photodynamic Therapy

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved January, 1996

Specific Treatments:

esophageal cancer

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Photodynamic Therapy (PDT) utilizes the light-activated drug, Photofrin, in combination with laser light of a specific wavelength and fiberoptic delivery devices to kill cancerous cells selectively with minimal side effects. The approval of PDT's laser system came in conjunction with the FDA approval of Photofrin to treat esophageal cancer.